Another complicating factor is the fact that PON1 is primarily synthesized in the liver, and individuals with obesity often exhibit non-alcoholic fatty liver disease (NAFLD), which could affect the measurement results. Here, PON1 is linked to metabolic dysfunction-associated steatotic liver disease.